Skip to content
  • Categories
  • Recent
  • Tags
  • Popular
  • Users
  • Groups
Skins
  • Light
  • Cerulean
  • Cosmo
  • Flatly
  • Journal
  • Litera
  • Lumen
  • Lux
  • Materia
  • Minty
  • Morph
  • Pulse
  • Sandstone
  • Simplex
  • Sketchy
  • Spacelab
  • United
  • Yeti
  • Zephyr
  • Dark
  • Cyborg
  • Darkly
  • Quartz
  • Slate
  • Solar
  • Superhero
  • Vapor

  • Default (No Skin)
  • No Skin
Collapse
Brand Logo

Forum

  1. Home
  2. PAAB Q&A
  3. Press Releases, Financial Reports, Unsolicited Requests
  4. 171 - If a physician who was not able to attend a congress/confrence(e.g. ASH, ASCO, ADA) requests through medical information slides on company studies presented at the congress are we allowed to provide them?
PAAB Notice
The responses, guidance, and advisories provided by the Pharmaceutical Advertising Advisory Board (PAAB), including but not limited to those available through the PAAB Forum, the PAAB website, and any PAAB correspondences, are specifically intended to assist individuals navigating the PAAB preclearance system. Repurposing or reproducing this content without written consent from the PAAB Commissioner is strictly prohibited. This prohibition includes, but is not limited to, use in machine learning or AI models.

171 - If a physician who was not able to attend a congress/confrence(e.g. ASH, ASCO, ADA) requests through medical information slides on company studies presented at the congress are we allowed to provide them?

Scheduled Pinned Locked Moved Press Releases, Financial Reports, Unsolicited Requests
1 Posts 1 Posters 201 Views
  • Oldest to Newest
  • Newest to Oldest
  • Most Votes
Reply
  • Reply as topic
Log in to reply
This topic has been deleted. Only users with topic management privileges can see it.
  • Jennifer CarrollJ Offline
    Jennifer CarrollJ Offline
    Jennifer Carroll
    wrote on last edited by
    #1

    The Health Canada policy document "The Distinction Between Advertising and Other Activities" does not consider responses to specific questions from a medical info department to be advertising. The request should be SPECIFIC and DOCUMENTED. Such a response would be exempt from PAAB preclearance review. We remind you that, while a company may promote the fact that it has a medical information service, it should not promote individual studies that are not consistent with the product's Terms of Market Authorization (TMA). If drugs are mentioned in an institutional message, even within study titles, PAAB preclearance review is required.

    1 Reply Last reply
    0
    Reply
    • Reply as topic
    Log in to reply
    • Oldest to Newest
    • Newest to Oldest
    • Most Votes


    • Login

    • Don't have an account? Register

    • Login or register to search.
    • First post
      Last post
    0
    • Categories
    • Recent
    • Tags
    • Popular
    • Users
    • Groups